Aptamer-target interaction descriptor
Aptamer-target interaction information
Interaction ID: 1273
Aptamer sequence: ACUAGCCUCAUCAGCUCAUGUGCCCCUCCGCCUGGAUCAC
Target unique ID: O15123
Aptamer ID Aptamer descriptor Target chemistry Target name Affinity Binding Conditions/Buffer PubMed ID
Apta_1211 Seq1 Protein ANGP2_HUMAN 2.2 nM N/A 25866800
Structure information of aptamer
Aptamer Sequence: ACUAGCCUCAUCAGCUCAUGUGCCCCUCCGCCUGGAUCAC
The optimal secondary structure in dot-bracket notation: .((((........((......))........)))).....
The centroid secondary structure in dot-bracket notation: ........................................
The MFE structure
The Centroid structure
The mountain plot representation
Aptamer information
Type Detail Type Detail
Aptamer ID Apta_1211 Description Seq1
Aptamer chemistry RNA Length 40 nt
GC content 60.0% Molecular weight 12,602.49 Da
Molarity of 1 μg/μl solution 79.35 μM Number of G-quadruplexes No QGRS found
G-Score N/A Function Targeted binding
Sequence ACUAGCCUCAUCAGCUCAUGUGCCCCUCCGCCUGGAUCAC
Applications Binding to angiopoietin-2
Target information
Type Detail Type Detail
Uniprot ID O15123 Protein name Angiopoietin-2 (ANG-2)
Gene name(s) ANGPT2 Organism Angiopoietin-2 (ANG-2)
Status reviewed in uniprot database Length 496
Mass 56,919 Activity regulation N/A
Involvement in disease Lymphatic malformation 10 (LMPHM10) Catalytic activity N/A
PDB ID(s)
1Z3S;1Z3U;2GY7;4JZC;4ZFG;
Function Binds to TEK/TIE2, competing for the ANGPT1 binding site, and modulating ANGPT1 signaling.
Activity data

No relevant experimental diagram

Interaction ID 1273
Target type Protein
Target unique ID O15123
Activity 2.2 nM
Binding Conditions/Buffer

N/A

Assay

N/A

PubMed ID 25866800
Similar aptamers
Aptamer ID Aptamer chemistry Sequence Similarity
Apta_1122 RNA ACAACCCGGAACAACGUCUAACAGUGUACCAUAACCCGGCAUUCA 53.33%
Apta_292 RNA CUACGAACUCAUGACACAAGGAUGCAAUCUCAUCCCGCCAGCCCACCGU 53.06%
Apta_1143 RNA ACGAGUUGUCGCAUGUGCGGUUCAGUCUGGUCCUUCAGCACCGUACAACAA 52.94%
Apta_1 RNA ACGAAGCUUGAUCCCGUUUGCCGGUCGAUCGCUUCGA 52.50%
Apta_384 RNA AUGAUCAAUCGCCUCAAUUCGACAGGAGGCUCAC 52.50%
Apta_709 RNA AGUGAUACCAGCAUCGUCUUGAUGCCCUUGGCAGCACU 52.50%
Apta_91 RNA GAUAACCUCGAUGCGACGUUCGGCCUCAAAAUCAA 50.00%
Apta_152 RNA UUACCACGCGCUCUUAACUGCUAGCGCCAUGGC 50.00%
Apta_172 RNA GGAGACAUCCCUCUUGUUGGUGGUGCCGUGUGGAUGUCUC 50.00%
Apta_314 RNA GGUUACCAGCCUUCACUGCUCCCGGACGCGUCUGUAUCCGCUACCCGCCGCACCACGGUCGGUCACAC 50.00%
Apta_603 RNA CUUGUCUGAACAAUUUCGUCUGCCUUUGCGUUCCGACGGC 50.00%
Apta_766 RNA GGUUACCAGCCUUCACUGCGGACGGACAGAGAGUGCAACCUGCCGUGCCGCACCACGGUCGGUCACAC 50.00%
Apta_575 RNA AGAGCUUGACGGUCCCGAGAGUCGAGCCCAAGCUGACACUGGACCUUUGCGGACCACGUGUUGAUCGUCG 48.57%
Apta_431 RNA CAGGCAUGCCUAGCUAAGCAGCCCAUGGCUUAUGCGCGGAAUAUUGGCUUCCGUUC 48.21%
Apta_269 RNA AACGCUCAACGUCAGAAGGCAACGUAUAGGCAAGCACACUUCGACAUGAGGC 48.08%
Apta_301 RNA AUACCAGCUUAUUCAAUUGCCUGAAAAGUUGAACUCCAAAUACGCGCUGAGAUAGUAAGUGCAAUCU 47.76%
Apta_242 RNA GCUUCCAGGAAGAGAAGUGUCAUGUGAUCAGUCCUGGUGGGUGG 47.73%
Apta_303 RNA CCUCCGGCUCAUACCUUUUCGAAGACAAGCUUCGACAGGAGG 47.62%
Apta_51 RNA GCCUUAGUAACGUGCUUUGAUGUCGAUUCGACAGGAGGC 47.50%
Apta_86 RNA GAAACGACUCGACAACCUCGAGCGACGUGAAUCAU 47.50%